Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT.
about
The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience.Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?The protective role of immunoglobulins in fungal infections and inflammation.Successful treatment of pulmonary candidiasis and aspergillosis in patient with refractory Hodgkin lymphoma using micafungin - case study and brief literature reviewNeutropenic enterocolitis after high-dose chemotherapy and autologous stem cell transplantation: incidence, risk factors, and outcome.Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China.Risk factors for invasive mold diseases in allogeneic hematopoietic cell transplant recipients.Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies.Risk stratification for invasive aspergillosis in immunocompromised patients.Invasive Fungal Infections in Patients with Chronic Lymphoproliferative Disorders in the Era of Target Drugs
P2860
Q34486116-3F4FD1F2-251F-4FE7-B230-728F6EE2B800Q37866827-1523B25B-4F02-44FA-9117-189543EF9692Q38268922-D151AA80-68A9-47E0-8FA0-C733AC30BA81Q39416431-39CA4334-DC2F-48D0-8431-019275A944A1Q40278682-125F2E76-E625-43F1-9948-27A2142C7439Q40515140-DF79D42E-A0BC-4BD3-B230-5FBEAB671D48Q40858856-DF0699C1-7FC3-4C8D-B6D6-07B12DB358F6Q42175368-5A71912F-CAA1-40A8-B6A9-CD119A3A0BFDQ43087338-F2E02F11-79F7-4D92-A73B-8C204CC4028AQ53119428-98E4EA05-FF6D-46D8-AB69-1208E87FE1BEQ58701117-59D1B45A-74E3-464B-B88E-2472DFCEE347
P2860
Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Increased risk for invasive as ...... autologous hematopoietic SCT.
@en
type
label
Increased risk for invasive as ...... autologous hematopoietic SCT.
@en
prefLabel
Increased risk for invasive as ...... autologous hematopoietic SCT.
@en
P2093
P2860
P356
P1476
Increased risk for invasive as ...... autologous hematopoietic SCT.
@en
P2093
D Poplawski
J Styczynski
M Komarnicki
M Kozlowska-Skrzypczak
P2860
P2888
P304
P356
10.1038/BMT.2008.303
P407
P577
2008-09-15T00:00:00Z
P5875
P6179
1012111455